Basal Cell Carcinoma: Diagnosis, Subtypes, and Surgical Management

Basal cell carcinoma is the most common cancer in the United States — not just the most common skin cancer, but the most common cancer of any kind. More than four million cases are diagnosed each year. Despite its frequency, BCC carries a very favorable prognosis when treated appropriately: it grows slowly, almost never metastasizes, and is nearly always curable with proper surgical management.

That said, “common” does not mean “harmless.” Untreated basal cell carcinoma can grow steadily for years, invading deeper tissue planes, eroding cartilage and bone, and causing significant functional and cosmetic damage — particularly on the face, ears, nose, and eyelids. The goal of treatment is complete removal before that destruction occurs.

At Sulphur Surgical Clinic, our surgeons provide expert evaluation and surgical management of basal cell carcinoma for patients throughout Southwest Louisiana. This post — Part 2 in our Skin Cancer Series — covers everything you need to know about BCC: what it is, how it presents, how it’s diagnosed, and how it’s treated.

What Is Basal Cell Carcinoma?

The skin is organized into distinct layers. The outermost layer, the epidermis, is itself composed of multiple sublayers. The deepest of these is the basal layer, home to the basal cells — small, round cells responsible for continuously producing new skin cells that migrate upward to replace those shed from the surface.

When basal cells sustain enough UV-induced DNA damage, they can begin to replicate abnormally. Rather than maturing and migrating normally, these cells proliferate uncontrolled, giving rise to basal cell carcinoma. Because basal cells don’t travel through the lymphatic or vascular system, BCC almost never metastasizes — but it does grow locally, and it does invade.

Who Is at Risk?

Basal cell carcinoma is predominantly a disease of cumulative sun exposure. Key risk factors include:

Fair skin — individuals with Fitzpatrick skin types I and II (burn easily, rarely tan) carry the highest risk
Prolonged or occupational UV exposure — outdoor workers, farmers, and fishermen face elevated lifetime risk
History of sunburns — especially in youth
Tanning bed use — indoor UV radiation significantly increases BCC risk, even in young adults
Personal or family history of skin cancer — having had one BCC increases the likelihood of developing another
Immunosuppression — organ transplant recipients and others on chronic immunosuppressive therapy develop BCC at higher rates
Gorlin syndrome (basal cell nevus syndrome) — a rare inherited condition associated with multiple BCCs beginning in early adulthood
Arsenic exposure — historically associated with BCC in certain occupational settings

Louisiana’s climate — intense sunshine, high UV index, and outdoor culture — makes skin cancer education and early detection particularly important for our community.

How Does BCC Present?

One of the challenges of basal cell carcinoma is that it can look quite different from one patient to the next. Common presentations include:

A shiny, pearly, or translucent pink, red, or white bump — often with a rolled border and small visible blood vessels (telangiectasias)
A flat, scar-like lesion that is flesh-colored or slightly pink — may appear innocuous for years before diagnosis
A pink or red patch with a slightly scaly or crusted surface — common on the trunk and shoulders
An ulcerated lesion with a central depression that bleeds easily and fails to heal
A pink growth with raised, curled edges and a central indentation

BCCs are most commonly found on the head and neck (over 80% of cases) — particularly the nose, cheeks, forehead, ears, and scalp. The hands and arms account for another significant portion. However, BCC can occur anywhere on the body, including areas with minimal sun exposure.

BCC Subtypes: Why They Matter

Not all basal cell carcinomas are created equal. The subtype of BCC has significant implications for treatment planning, margin requirements, and recurrence risk.

Nodular BCC

The most common subtype, accounting for approximately 60% of all BCCs. Presents as a well-defined, dome-shaped nodule — often pearly or translucent — with a rolled border and visible surface vessels. It may develop a central ulceration (“rodent ulcer”) over time. Nodular BCC is well-defined and responds well to standard surgical excision.

Superficial BCC

Presents as a thin, red or pink scaly patch that spreads horizontally across the skin surface. Common on the trunk, shoulders, and back. Superficial BCC tends to be multifocal — meaning multiple areas of involvement may exist within a single lesion. It is typically less aggressive than other subtypes but requires careful attention to ensure complete margins.

Infiltrative BCC

A more aggressive variant that grows in slender strands or cords that extend beyond the visible borders of the lesion. What appears to be a small, localized tumor on the surface may have significant subclinical spread. Infiltrative BCC requires wider excision margins and more careful histologic margin assessment.

Morpheaform (Sclerosing) BCC

The most challenging subtype to treat. Morpheaform BCC appears as a firm, scar-like plaque — often flesh-colored or slightly yellowish — with poorly defined edges. It may look like nothing more than a small scar or area of induration, but it grows in deep, aggressive fingers of tumor that extend well beyond the visible border. Standard clinical margin assessment frequently underestimates the true extent of morpheaform BCC.

Micronodular and Basosquamous BCC

Micronodular BCC grows in small nests with extensive subclinical spread. Basosquamous (metatypical) BCC has features of both BCC and squamous cell carcinoma and carries a higher risk of metastasis than classic BCC — though still quite low.

Diagnosis

Biopsy

Diagnosis of BCC is established by skin biopsy. A small sample of the suspicious lesion is removed and sent for histopathologic analysis. Common biopsy techniques include:

Shave biopsy — a superficial horizontal section of the lesion; quick and appropriate for raised lesions
Punch biopsy — a small cylindrical core of full-thickness skin; useful for assessing depth and subtype
Excisional biopsy — removal of the entire lesion with a margin of normal skin; diagnostic and potentially therapeutic for small lesions

The pathology report confirms the diagnosis, identifies the BCC subtype, and assesses whether the biopsy margins are clear.

Surgical Management of Basal Cell Carcinoma

Surgery is the gold standard treatment for basal cell carcinoma. The goal is complete removal of the tumor with histologically confirmed clear margins. The two primary surgical approaches are standard excision and Mohs micrographic surgery.

Standard Surgical Excision

Standard excision involves removing the visible tumor along with a predetermined margin of normal-appearing surrounding tissue. The excised specimen is sent to pathology for standard margin analysis.

Recommended excision margins for BCC depend on tumor characteristics:

Low-risk BCC (small, well-defined, nodular or superficial subtype, non-facial location): 4 mm peripheral margins are recommended and achieve cure rates above 95%
High-risk BCC (large lesions, infiltrative or morpheaform subtype, recurrent tumors, facial involvement): wider margins — often 5 to 10 mm or more — and careful margin assessment are required

After excision, the wound is closed primarily (side-to-side closure), with a local tissue flap, or with a skin graft, depending on the size and location of the defect. Our surgeons pay close attention to functional and aesthetic outcomes, particularly for lesions on the face and neck.

Mohs Micrographic Surgery

Mohs surgery is a specialized technique performed by Mohs surgeons (typically fellowship-trained dermatologists) in which the tumor is removed in sequential layers, with each layer examined immediately under the microscope before proceeding. The procedure continues until all margins are clear. Because 100% of the surgical margin is examined — compared to the representative sections assessed in standard pathology — Mohs surgery offers the highest cure rates for appropriate lesions, along with maximum tissue conservation.

Mohs surgery is particularly valuable for:

BCCs in cosmetically and functionally critical locations (nose, eyelids, ears, lips)
Morpheaform and infiltrative subtypes with poorly defined borders
Large or recurrent BCCs
BCCs in areas where tissue conservation is paramount

At Sulphur Surgical Clinic, we coordinate closely with dermatology and Mohs surgery practices to ensure patients receive the most appropriate treatment modality for their specific tumor. When complex reconstruction is needed following Mohs excision, our surgical team is equipped to perform flap and graft repairs.

Wound Closure and Reconstruction

Depending on the size, depth, and location of the defect following excision, wound closure may involve:

Primary closure — direct side-to-side suture; appropriate for smaller defects where adequate skin laxity exists
Local advancement or rotation flaps — tissue is mobilized from adjacent areas to close the defect; preserves natural skin texture and color
Full-thickness or split-thickness skin grafts — used when local tissue is insufficient for primary closure
Second-intention healing — smaller defects in certain anatomical locations may be allowed to heal naturally with appropriate wound care

Our team discusses reconstruction options with each patient prior to surgery, with the goals of complete tumor removal, preserved function, and the best possible cosmetic outcome.

Prognosis and Recurrence

The overall cure rate for properly treated primary BCC exceeds 95%. However, recurrence is possible — particularly with:

Incomplete initial excision (positive margins)
Morpheaform or infiltrative subtype
Facial location, especially the nose, nasolabial fold, ear, and periorbital areas
Large tumor size or deep invasion
Immunosuppression

Patients who have had one BCC are at significantly elevated risk for developing additional BCCs — as many as 40% develop a second BCC within five years. Regular follow-up, diligent sun protection, and annual skin examinations are essential.

What to Expect at Sulphur Surgical Clinic

When you’re referred to us or come in for evaluation of a possible skin cancer, here’s what you can expect:

Consultation: We review your history, examine the lesion, and discuss the findings with you. If a biopsy has already been performed by your dermatologist, we review the pathology report. If not, we may perform or arrange a diagnostic biopsy.

Pre-operative planning: We discuss surgical margin requirements, anesthesia options (most skin cancer excisions are performed under local anesthesia in an outpatient setting), and wound closure or reconstruction plans.

Surgery: Most excisions are performed as outpatient procedures. The procedure typically takes less than an hour. You return home the same day.

Pathology review: All excised tissue is sent for margin analysis. We contact you promptly with results and discuss next steps if margins require re-excision.

Follow-up: We schedule appropriate wound checks and discuss long-term surveillance.

Continue Reading: The SSC Skin Cancer Series

Part 1: Skin Cancer 101 — Understanding Basal Cell, Squamous Cell, and Melanoma
Part 3: Squamous Cell Carcinoma — Diagnosis and Surgical Management
Part 4: Melanoma — Surgical Management, Sentinel Lymph Node Biopsy, and Staging

To schedule a consultation at Sulphur Surgical Clinic, call (337) 527-6363 or visit sulphursurgicalclinic.com. We serve patients throughout Southwest Louisiana, at two convenient locations: 914 Cypress Street, Sulphur LA 70663 and our new Lake Charles office at 1920 W Sale Rd, Lake Charles LA 70605.